Psychedelic use and bipolar disorder – An investigation of recreational use and its impact on mental health
- 13 December 2024
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 373, 505-511
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical EvidenceCNS Drugs, 2023
- Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders, 2023
- Psychedelic therapy for depressive symptoms: A systematic review and meta-analysisJournal of Affective Disorders, 2022
- Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use DisorderJAMA Psychiatry, 2022
- Evaluating the risk of psilocybin for the treatment of bipolar depression: A review of the research literature and published case studiesJournal of Affective Disorders Reports, 2021
- Psychedelics: Where we are now, why we got here, what we must doNeuropharmacology, 2018
- Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances — Systematic review and meta-analysisAddictive Behaviors, 2012
- Accuracy of recall for mania symptoms using a three month timeline follow-back interviewJournal of Affective Disorders, 2008
- A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II DisorderArchives of General Psychiatry, 2003
- The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I DisorderArchives of General Psychiatry, 2002